Early (fifth day) vs. late (sixth month) steroid withdrawal in renal transplant recipients treated with Neoral® plus Rapamune®: Four-yr results of a randomized monocenter study

Clinical Transplantation

Volumn 24, Issue 5, 2010, Pages 669-677

  Sandrini, Silvio ^a   Setti, Gisella ^a   Bossini, Nicola ^a   Chiappini, Raffaella ^a   Valerio, Francesca ^a   Mazzola, Giuseppe ^a   Maffeis, Roberto ^a   Nodari, Franco ^a   Cancarini, Giovanni ^a  

^a SPEDALI CIVILI   (Italy)

Author keywords

Acute rejection; Early steroid withdrawal; Late steroid withdrawal; Renal transplantation; Steroid withdrawal

Indexed keywords

BASILIXIMAB; CYCLOSPORIN A; METHYLPREDNISOLONE; RAPAMYCIN; THYMOCYTE ANTIBODY;

ARTHRALGIA; ARTICLE; BACTERIAL INFECTION; BACTERIAL POLMONITIS; CONTROLLED STUDY; DIABETES MELLITUS; DIARRHEA; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG WITHDRAWAL; DYSLIPIDEMIA; EDEMA; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HYPERTHRICOSIS; INFECTION; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; LOADING DRUG DOSE; LONG TERM CARE; LYMPHOCELE; MAJOR CLINICAL STUDY; MOUTH DISEASE; MOUTH ULCER; NEOPLASM; ORAL APHTHOSIS; PRIORITY JOURNAL; SKIN APPENDAGE DISEASE; TREATMENT OUTCOME; VIRUS INFECTION; WOUND HEALING;

ANTI-INFLAMMATORY AGENTS; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; METHYLPREDNISOLONE; MIDDLE AGED; SIROLIMUS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 78650481224     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2009.01171.x     Document Type: Article

References (31)

1. Siegel RR, Luke RG, Hellebush AA. Reduction of toxicity of corticosteroid therapy after renal transplantation. Am J Med 1972: 53: 159.
2. Turcotte JG, Dickerman RM, Harper ML. Minimum steroid requirements in the late post-transplant period. Transplant Proc 1975: 8: 83.
3. Naik RB, Abdeen H, English J et al. Prednisolone withdrawal after 2 years in renal transplant patients receiving only this form of immunosuppression. Transplant Proc 1979: 9: 39.
4. Hricik DE, Schulak JA. Steroid withdrawal from cyclosporine-based regimens: con-a flawed strategy. Transplant Proc 1998: 30: 1785.
5. Hricik DE, Whallen CC, Lautman J. Withdrawal of steroids after renal transplantation. Clinical predictors of outcome. Transplantation 1992: 53: 41.
6. Woodle ES, Alloweay RR, Buell JF. Multivariate analysis of risk factor for acute rejection in early corticosteroid cessation regimens under modern immunosoppressione. Am J Transplant 2005: 5: 2740.
7. Humar A, Payne WD, Sutherland D et al. Clinical determinants of multiple acute rejection episodes in kidney transplant recipients. Transplantation 2000: 69: 2357.
8. Julian BA, Laskow DA, Dubovsky J et al. Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 1991: 325: 544.
9. Ponticelli C. Steroid-free immunosuppression. Transplant Proc 2001: 33: 3259.
10. Sandrini S, Setti G, Bossini N et al. Steroid withdrawal five days after renal transplantation allows for the prevention of wound-healing complication associated with sirolimus therapy. Clin Transplant 2009: 23: 16.
11. Solez K, Axelsen SA, Benediktsson H et al. International standardisation of criteria for histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1997: 44: 411.
12. Kasiske BL, Chakkera HA, Louis TA et al. A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol 2000: 11: 1910.
13. Pascual J, Quereda C, Zamora J et al. Steroid withdrawal in renal transplant patients on triple therapy with calcineurine inhibitor and mycophenolate mofetil: a meta-analysis of randomized, controlled trials. Transplantation 2004: 78: 1548.
14. Montagnino G, Tarantino A, Segolini GP et al. Long-term results of a randomized study comparino three immunosuppressive schedules with cyclosporine in cadaveric kidney transplantation. J Am Soc Nephrol 2001: 12: 2163.
15. Montagnino G, Sandrini S, Cascinai C et al. A randomized trial of steroid avoidance in renal transplant patients treated with everolimus and cyclosporine. Transplant Proc 2005: 37: 788.
16. Gallon L, Perico N, Dimitrov BD et al. Long-term renal allograft function on a tacrolimus-based, pred-free maintenance immunosuppression comparing sirolimus vs. MMF. Am J Transplant 2006: 6: 1617.
17. Gallon LG, Winoto J, Leventhal JR, Leventhal JR, Parker MA, Kaufman DB. Effect of prednisone versus no prednisone as part of maintenance immunosuppression on long-term renal transplant function. Clin J Am Soc Nephrol 2006: 1: 1029.
18. Vincenti F, Schena FP, Paraskevas S et al. A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplantation recipients. Am J Transplant 2008: 8: 307.
19. Vincenti F. Interleukin-2 receptor antagonists and aggressive steroid minimization strategies for kidney transplant patients. Transpl Int 2004: 17: 395.
20. Naik RB, Abdeen H, Enhlish J et al. Prednisolone withdrawal after 2 years in renal transplant patients receiving only this form of immunosuppression. Transplant Proc 1979: 11: 39.
21. Montagnino G, Sandrini S, Iorio B et al. A randomized exploratory trial of steroid avoidance in renal transplant patients treated with everolimus and low-dose cyclosporine. Nephrol Dial Transplant 2008: 23: 707.
22. Opelz G, Döhler B, Laux G. Long-term prospective study of steroid withdrawal in kidney and heart transplant recipients. Am J Transplant 2005: 5: 720.
23. Beik AI, Higgins RM, Lam FT, Morris AG. Steroid withdrawal and donor-specific hyporeactivity after cadaver renal allotransplantation on maintenance triple therapy. Nephrol Dial Transplant 1997: 12: 1949.
24. Podder H, Stepkowski SM, Napoli KL et al. Pharmacokinetic interactions augment toxicities of sirolimus/cyclosporine combinations. J Am Soc Nephrol 2001: 12: 1059.
25. Kahan BD, Podbilski J, Schoenberg L. Use of sirolimus to facilitate steroid withdrawal from a cyclosporine regimen. Transplant Proc 2006: 38: 2842.
26. Woodle ES, Vincenti F, Lorber MI et al. A multicenter pilot study of early (4-days) steroid cessation in renal transplant recipients, tacrolimus and sirolimus. Am J Transplant 2005: 5: 157.
27. Kumar MSA, Saeed MI, Ranganna K et al. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes. Transpl Immunol 2008: 20: 32.
28. Vincenti F, Monaco A, Grinyo J et al. Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil. Am J Transplant 2003: 3: 306.
29. Vanrenterghem Y, Lebranchu Y, Hene R et al. Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil: a prospective randomized study. Transplantation 2000: 70: 1352.
30. Vitko S, Tedesco H, Eris J et al. Everolimus with optimized cyclosporine dosing in renal transplant recipients: 6-month safety and efficacy results of two randomized studies. Am J Transplant 2004: 4: 626.
31. Pascual J. Concentration-controlled everolimus (Certican): combination with reduced dose calcineurin inhibitors. Transplantation 2005: 9(Suppl.): S76.